ORASURE TECHNOLOGIES, INC Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ORASURE TECHNOLOGIES, INC stock issued during period, value, stock options exercised for the quarter ending 2024-03-31 was $214.00K, a 224.24% increase year-over-year.
- ORASURE TECHNOLOGIES, INC stock issued during period, value, stock options exercised for the quarter ending 2023-09-30 was $10.00K.
- ORASURE TECHNOLOGIES, INC stock issued during period, value, stock options exercised for the quarter ending 2023-06-30 was $0.00.
- ORASURE TECHNOLOGIES, INC stock issued during period, value, stock options exercised for the quarter ending 2023-03-31 was $66.00K, a 0.00% change year-over-year.
- ORASURE TECHNOLOGIES, INC stock issued during period, value, stock options exercised for fiscal 2024 was $214.00K, a 20.45% decline from fiscal 2023.
- ORASURE TECHNOLOGIES, INC stock issued during period, value, stock options exercised for fiscal 2023 was $269.00K, a 1693.33% increase from fiscal 2022.
- ORASURE TECHNOLOGIES, INC stock issued during period, value, stock options exercised for fiscal 2022 was $15.00K, a 93.90% decline from fiscal 2021.
- ORASURE TECHNOLOGIES, INC stock issued during period, value, stock options exercised for fiscal 2021 was $246.00K, a 92.36% decline from fiscal 2020.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2024-12-31 | $214.00K 10-K · filed 2026-03-09 | |
| 2024-03-31 | $214.00K 10-Q · filed 2025-11-05 | |
| 2023-12-31 | $269.00K 10-K · filed 2026-03-09 | |
| 2023-09-30 | $10.00K 10-Q · filed 2024-11-06 | |
| 2023-06-30 | $0.00 10-Q · filed 2024-11-06 | |
| 2023-03-31 | $66.00K 10-Q · filed 2024-11-06 | |
| 2022-12-31 | $15.00K 10-K · filed 2025-03-07 | |
| 2022-06-30 | $0.00 10-Q · filed 2023-11-08 | |
| 2022-03-31 | $66.00K 10-Q · filed 2024-05-09 | |
| 2021-12-31 | $246.00K 10-K · filed 2024-03-11 | |
| 2021-09-30 | $126.00K 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $29.00K 10-Q · filed 2022-11-08 | |
| 2021-03-31 | $92.00K 10-Q · filed 2022-11-08 | |
| 2020-12-31 | $3.22M 10-K · filed 2023-03-03 | |
| 2020-09-30 | $1.55M 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $530.00K 10-Q · filed 2021-11-04 | |
| 2020-03-31 | $30.00K 10-Q · filed 2021-11-04 | |
| 2019-12-31 | $196.00K 10-K · filed 2022-03-01 | |
| 2019-06-30 | $147.00K 10-Q · filed 2020-11-05 | |
| 2019-03-31 | $22.00K 10-Q · filed 2020-11-05 | |
| 2018-12-31 | $1.70M 10-K · filed 2021-03-01 | |
| 2018-09-30 | $483.00K 10-Q · filed 2019-11-08 | |
| 2018-06-30 | $222.00K 10-Q · filed 2019-11-08 | |
| 2018-03-31 | $974.00K 10-Q · filed 2019-11-08 | |
| 2017-12-31 | $31.67M 10-K · filed 2020-03-02 | |
| 2016-12-31 | $2.66M 10-K · filed 2019-02-28 | |
| 2015-12-31 | $404.00K 10-K · filed 2018-02-28 | |
| 2014-12-31 | $1.11M 10-K · filed 2017-03-14 | |
| 2013-12-31 | $409.00K 10-K · filed 2016-03-14 | |
| 2012-12-31 | $10.04M 10-K · filed 2015-03-12 | |
| 2011-12-31 | $4.78M 10-K · filed 2014-03-14 | |
| 2010-12-31 | $8.00K 10-K · filed 2013-03-13 | |
| 2009-12-31 | $24.81K 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |